Aurinia Pharmaceuticals Inc (AUPH)
Deferred Revenue
$10.59M
Quarterly · Period ending: · USD
AUPH Deferred Revenue
Latest reported$10.59Mperiod ending
Latest reported$10.59Mperiod ending
AUPH Quarterly Deferred Revenue (-$0.00 → $10.59M)
Quarterly deferred revenue
High-resolution chart · PNG
AUPH deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 10,593,000 | |
| 5,036,000 | |
| 3,720,000 | |
| 4,602,000 | |
| 5,499,000 | |
| 4,594,000 | |
| 11,002,000 | |
| 4,304,000 | |
| 4,367,000 | |
| 4,909,000 | |
| 4,813,000 | |
| 4,662,000 | |
| 3,228,000 | |
| 3,157,000 | |
| 3,148,000 | |
| 0 | |
| 0 | |
| 0 | |
| 190,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 118,000 | |
| 0 | |
| 0 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 118,000 | |
| 143,000 | |
| 168,000 | |
| 193,000 | |
| 217,000 | |
| 217,000 | |
| 217,000 | |
| 217,000 | |
| 218,000 | |
| 217,000 | |
| 227,279 | |
| 293,724 | |
| 323,144 | |
| 333,185 | |
| 339,756 | |
| 307,848 | |
| 297,905 | |
| 303,695 | |
| 1,220,372 | |
| 866,339 | |
| 1,171,891 | |
| 1,211,017 | |
| 474,924 | |
| 1,803,644 | |
| 559,719 | |
| 921,130 | |
| 1,186,133 | |
| 1,567,031 | |
| 1,803,695 | |
| 692,959 | |
| 1,092,851 | |
| 2,210,466 | |
| 384,161 | |
| 379,869 | |
| 394,829 | |
| 419,016 | |
| 417,097 | |
| 408,287 | |
| 643,445 | |
| 1,156,188 | |
| 2,127,086 | |
| 1,911,991 | |
| 3,004,132 | |
| 1,500,021 | |
| -0 | |
| 0 | |
| 0 | |
| -0 | |
| -0 | |
| -0 | |
| 564,479 | |
| 0 | |
| 1 | |
| 1 | |
| 0 | |
| 1 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |